Loading...
Loading...
Quantum Biopharma Ltd.
Quantum Biopharma Ltd.. Spoken Alpha tracks QNTM's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks QNTM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for QNTM.
curl https://api.spokenalpha.com/v1/companies/QNTM| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.58 | $1.28 | +23.6% | -1.7% | +1.0% |
| Q4 FY2026 | $1.85 | $1.56 | +18.8% | -5.8% | -3.4% |
| Q3 FY2026 | $1.75 | $1.40 | +25.3% | +0.5% | +0.3% |
| Q2 FY2026 | $1.79 | $1.41 | +27.1% | -6.7% | -4.2% |
| Q1 FY2025 | $1.70 | $1.40 | +21.2% | -6.7% | -6.0% |
| Q4 FY2025 | $1.91 | $1.66 | +14.8% | +2.3% | +5.3% |
| Q3 FY2025 | $1.77 | $1.57 | +13.0% | -1.8% | -3.2% |
| Q2 FY2025 | $1.74 | $1.44 | +20.9% | -1.0% | -1.8% |
| Q1 FY2024 | $1.90 | $1.58 | +20.2% | +2.6% | +4.3% |
| Q4 FY2024 | $1.93 | $1.57 | +22.8% | +0.4% | -1.0% |